Sutphin J, Okafor S, Reed S D, Deb A, Silver J, Wallace M J, Yang J-C, Abi Hachem R, Jang D W
Duke Clinical Research Institute, Duke University, Durham, NC, USA.
Department of Head and Neck Surgery and Communication Sciences, Duke University School of Medicine, Durham, NC, USA.
Rhinology. 2025 Apr 1;63(2):245-247. doi: 10.4193/Rhin24.475.
Choosing between revision endoscopic sinus surgery (ESS) versus biologic therapy for recurrent chronic rhinosinusitis with nasal polyposis (CRSwNP) is a complex, multifaceted decision that involves not only clinical and financial factors but also patient preferences. Currently, there are no quantitative studies investigating patient preferences for CRSwNP treatment options. Increased awareness of patient-centered approaches to treatment warrant further investigation.
